eurofeedback for Osteoarthritic Knee Pai

Not Applicable

Completed

• Conditions: Osteoarthitic Knee Pain; Musculoskeletal - Osteoarthritis

• Registration Number: ACTRN12620000273987
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-02
• Study Completion: 2020-12-16
• Last Update Posted: 5 July 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Adults aged 44-75 years, with a clinical diagnosis of knee OA; with pain (at least = four on an 11-point numerical rating scale) for a minimum duration of three months will be eligible to participate in the study.

Exclusion Criteria

•Underwent surgery or other invasive procedures in the last six months and any surgical procedures scheduled within 8 weeks after screening.
•Undertaken any steroid injections to the knee joint in the past three months or on oral steroids in the previous month.
•Current intake of centrally acting medications (e.g. antidepressants, anticonvulsants, neuropathic pain drugs) or intention of taking new medications in the next 8 weeks.
•Neurological conditions/diseases (brain, spinal cord or peripheral nerve injuries, radiculopathy and neuropathies).
•Soft tissue injuries of the knee (e.g. meniscus/muscle/tendon/ligament injury) in the last 3 months.
•Cognitive impairments (dementia, post-traumatic stress disorders, Alzheimer’s disease).
•Difficulty or inability to read or understand English.
•Hearing problems (hearing loss, tinnitus) and ear infections.
•Pregnancy or six months post-labour.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recruitment rate: The number of participants attending screening assessment will be assessed using participant data from the study records. [Monthly for the first three months of the recruitment period (February, March and April, 2020)];Randomization rate: a ratio of the number of participants willing to be randomized into the trial from amongst those eligible. This will be assessed using the participant data from the study records.[Monthly for the first three months of the recruitment period (February, March and April, 2020)];Retention rate: The number of sessions attended by the participant will be assessed from the individual participant data from the study records.[Monthly for the first four months of the intervention period (February, March, April, & May 2020)<br>]